SNS Subscriber Edition • Volume 24, Issue 6 • Week of February 18, 2019

 THE STRATEGIC NEWS SERVICE ©
GLOBAL REPORT ON
TECHNOLOGY AND
THE ECONOMY

Gene Editing
and Medicine


A Conversation with
Clayton Lewis
and Ben Brown


Moderated by
David Ewing Duncan


 


 
 
 
 
 

SNS: Gene Editing and Medicine

A Conversation with Clayton Lewis and Ben Brown

Moderated by David Ewing Duncan

 

In This Issue
Week of 2/18/2019 Vol. 24 Issue 6

____________

April in New York with SNS!

Sign Up Now for our 14th annual
SNS New York Dinner



New year, new season, new month, new tilt - Returning to the elegant ...

Lotte New York Palace Hotel
455 Madison Ave., New York
Thursday, April 25, 6pm

With SNS CEO Mark Anderson and special guest Bill Ribaudo,
Managing Partner, Digital Risk Venture Portfolio, Deloitte & Touche

Register Now at www.stratnews.com/events/newyork-dinner/


Many thanks to SNS Gold Platinum Partner Oracle:

Oracle

And to Deloitte for its generous sponsorship of this special evening:

dell-new_logo

 



Publisher's Note: If there is a single "north star" around which the constellations of the many revolutions in healthcare rotate today, that star would be the concept of how, at every level, biology tends to organize and act in networks - or, as Ben Brown refers to them below, consortia. Linked directly to this new understanding of the meta-systems of life are the new systems in machine learning which, for the first time, are capable of looking at increasingly complex, higher-order data sets.

For those SNS members who have attended FiRe and heard global leaders such as Leroy Hood, Larry Smarr, Lee Hartwell, and many others talk about this new level of science, this has become one of the most intellectually rewarding and exciting threads in the space between life and computing.

For those of us on the technology side of things, it provides concrete guidance toward new innovations in a plethora of areas, including but not limited to signal processing, compute systems design, message-based protocols, new programming methods, low-energy processing, and a nearly infinite number of other ongoing and future areas of improvement.

For those of us on the bio side of this conversation, it provides almost daily upgrades in the tools we can use to understand life in ever more complete ways - not just the genome, metabolome, proteome, or microbiome, but also how these act and signal together.

There is little in the technology universe more exciting than the lessons we are gleaning from biology, and little in the bio universe more exciting than the new discoveries we are finding with the help of machine learning.

In this week's discussion, members will have a chance to get a critical update from global leaders on both sides of this productive conversation, and no doubt will find their own sources of inspiration for creating next-generation ideas and products. - mra


Gene Editing and Medicine

A Conversation with Clayton Lewis, CEO, Arivale; and Ben Brown,
Dept. Head, Molecular Ecosystems Biology, and Chair, Environmental Bioinformatics, Lawrence Berkeley National Laboratory

Moderated by David Ewing Duncan, Author and Co-Founding CEO, Arc Programs

FiRe 2018 Conference
Wednesday, October 10, 2018 - Stein Eriksen Deer Valley - Park City, Utah

Photos 2018 Sally Anderson and Future in Review

L-R: David Ewing Duncan, Clayton Lewis, and Ben Brown

David Ewing Duncan: We're going to do a little bit of a deep dive, inasmuch as we have a few minutes to do that, in molecular space, targeted therapeutics, gene editing - things like that - and kind of walk you through a little bit of that.

...



SNS Member's please login to view the report >>

OR

Signup for a free trial now >>


Share this: Share on Facebook Tweet about this on Twitter Share on Google+ Share on LinkedIn Email this to someone